19972020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Filippo Montemurro is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 56 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report

Benvenuti, S., Milan, M., Geuna, E., Pisacane, A., Senetta, R., Gambardella, G., Stella, G. M., Montemurro, F., Sapino, A., Boccaccio, C. & Comoglio, P. M., Jan 1 2020, (Accepted/In press) In : EMBO Molecular Medicine.

Research output: Contribution to journalArticle

Open Access
  • Endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: extending endocrine sensitivity

    Frassoldati, A., Biganzoli, L., Bordonaro, R., Cinieri, S., Conte, P., Laurentis, M. D., Mastro, L. D., Gori, S., Lauria, R., Marchetti, P., Michelotti, A., Montemurro, F., Naso, G., Pronzato, P., Puglisi, F. & Tondini, C. A., Feb 1 2020, In : Future Oncology. 16, 5, p. 129-145 17 p.

    Research output: Contribution to journalArticle

  • Endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: extending endocrine sensitivity

    Frassoldati, A., Biganzoli, L., Bordonaro, R., Cinieri, S., Conte, P., Laurentis, M. D., Mastro, L. D., Gori, S., Lauria, R., Marchetti, P., Michelotti, A., Montemurro, F., Naso, G., Pronzato, P., Puglisi, F. & Tondini, C. A., Feb 1 2020, In : Future oncology (London, England). 16, 5, p. 129-145 17 p.

    Research output: Contribution to journalArticle

  • Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies

    Cazzaniga, M. E., Verusio, C., Ciccarese, M., Fumagalli, A., Sartori, D., Valerio, M. R., Airoldi, M., Moretti, G., Ficorella, C., Gianni, L., Michelotti, A., Zambelli, A., Febbraro, A., Generali, D., Pistelli, M., Garrone, O., Musolino, A., Vici, P., Maur, M., Mentuccia, L. & 31 others, La Verde, N., Bianchi, G. V., Artale, S., Blasi, L., De Laurentiis, M., Atzori, F., Turletti, A., Porpiglia, M., Santini, D., Fabi, A., Gebbia, V., Schirone, A., Palumbo, R., Ferzi, A., Frassoldati, A., Scavelli, C., Clivio, L., Giordano, M., Donadio, M., Biganzoli, L., Del Mastro, L., Bisagni, G., Livi, L., Natoli, C., Montemurro, F., Riccardi, F., Romagnoli, E., Marchetti, P., Torri, V., Pronzato, P. & Mustacchi, G., Jan 1 2020, In : Breast Care. 15, p. 30-37 8 p.

    Research output: Contribution to journalArticle

  • A new player in the treatment of HER2-positive tumours

    Giannone, G. & Montemurro, F., Jun 2019, In : The Lancet. Oncology. 20, 6, p. 748-750 3 p.

    Research output: Contribution to journalArticle